期刊文献+

不同病理分型混合型肝癌的超声造影特征分析 被引量:1

Analysis of contrast-enhanced ultrasound features of mixed hepatocellular carcinoma with different pathological types
下载PDF
导出
摘要 目的:观察混合型肝癌(CHC)的临床及超声造影特征,并探讨不同病理分型CHC的超声造影表现差异。方法:回顾性分析经手术病理确诊为CHC患者的临床病理及超声图像,总结其超声造影特征并对不同病理分型CHC的超声造影表现进行比较。结果:共纳入49例CHC患者,其中经典型27例,以HCC成分为主型21例,以ICC成分为主型25例,HCC与ICC比例相等型3例。灰阶超声表现:CHC病灶内部以低回声为主(79.6%),多表现为边界不清、形态不规则的实质性肿块。超声造影表现:20例(40.8%)CHC病灶动脉期增强方式为整体均匀增强,23例(46.9%)整体不均匀增强,6例(12.2%)环状增强;26例(53.1%)表现为显著消退,16例(32.7%)为轻度消退。以肝细胞肝癌(HCC)成分为主的病灶多表现为整体均匀(57.1%,12/21)或不均匀增强(42.9%,9/21),而以肝内胆管细胞癌(ICC)为主要成分的病灶多呈整体不均匀增强(48.0%,12/25)或环状增强(24.0%,6/25)。经典型CHC病灶平均消退时间短于伴干细胞特征型CHC(P<0.05),两者其余超声造影表现差异无统计学意义。结论:CHC超声造影表现与病理分型有关,不同细胞成分CHC病灶超声造影增强模式存在差异,经典型CHC与伴干细胞特征型CHC造影剂消退时间存在差异。 Objective:To investigate the contrast-enhanced ultrasound(CEUS)imaging features of combined hepatocellular carcinoma(CHC)and to explore the differences in the CEUS images of different pathological types of CHC.Methods:The pathological and ultrasound images of patients with pathological-confirmed CHC were retrospectively analyzed.CEUS features were summarized and compared between different pathological types of CHC.Results:A total of 49 CHC patients were enrolled,including 27 cases of classic type and 22 cases with stem cell characteristics.There were 21 cases with HCC component as the main type,25 cases with ICC component as the main type,and 3 cases with the same ratio of HCC and ICC.On gray-scale ultrasound,the interior of CHC lesions was mainly hypoechoic(79.6%),most of which presented as solid masses with unclear boundary and irregular shape.On CEUS,the enhancement patterns in the arterial phase of CHC lesions were overall uniform enhancement in 20 cases(40.8%),overall non-uniform enhancement in 23 cases(46.9%),and annular enhancement in 6 cases(12.2%).Significant attenuation was observed in 26 cases(53.1%)and mild resolution was observed in 16 cases(32.7%).The lesions mainly composed of hepatocellular carcinoma(HCC)were generally uniform(57.1%,12/21)or inhomogeneous enhancement(42.9%,9/21),while those mainly composed of intrahepatic cholangiocarcinoma(ICC)were generally inhomogeneous enhancement(48.0%,12/25)or annular enhancement(24.0%,6/25).The average attenuation time of classic CHC lesions was earlier than that of stem cell-associated CHC(P<0.05),and there was no significant difference between the other CEUS findings of the two groups.Conclusions:There are differences in CEUS patterns of CHC lesions with different cell components.Attenuation time between classical CHC and CHC with stem cell characteristics is statisticallydifferent.CEUS is correlated with pathological characteristics of CHC.
作者 陈彦玲 朱宇莉 陈凯玲 张炜彬 汪瀚韬 王文平 CHEN Yan-ling;ZHU Yu-li;CHEN Kai-ling;ZHANG Wei-bin;WANG Han-tao;WANG Wen-ping(Department of Ultrasound,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Shanghai Institute of Medical Imaging,Fudan University,Shanghai 200032,China)
出处 《中国临床医学》 2021年第6期974-979,共6页 Chinese Journal of Clinical Medicine
基金 上海市临床重点专科项目(shslczdzk03501) 上海申康中心重大临床研究项目(SHDC2020CR1031B) 上海市自然科学基金(20ZR1452800).
关键词 混合型肝癌 超声造影 病理分型 combined hepatocellular cholangiocarcinoma contrast-enhanced ultrasound pathological type
  • 相关文献

参考文献4

二级参考文献24

  • 1Xian-Huan Yu,Lei-Bo Xu,Hong Zeng,Rui Zhang,Jie Wang and Chao LiuAuthor Affiliations:Department of Hepato-Pancreato-Biliary Surgery and Department of Pathology,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,Guangzhou 510120,China.Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(6):620-625. 被引量:7
  • 2Gao, Chun,Yao, Shu-Kun.Diabetes mellitus: a “true” independent risk factor for hepatocellular carcinoma?[J].Hepatobiliary & Pancreatic Diseases International,2009,8(5):465-473. 被引量:23
  • 3Zuo, Huai-Quan,Yan, Lu-Nan,Zeng, Yong,Yang, Jia-Ying,Luo, Hong-Zhi,Liu, Jiang-Wen,Zhou, Li-Xin.Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2007,6(2):161-165. 被引量:13
  • 4赵峰,许顺良,林坚,郑继爱.26例混合细胞性肝癌的CT和MRI诊断[J].中国临床医学影像杂志,2010,21(11):804-806. 被引量:14
  • 5William C. Palmer,Tushar Patel.Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma[J].Journal of Hepatology.2012(1)
  • 6Zongtang Sun,Taoyang Chen,Snorri S. Thorgeirsson,Qimin Zhan,Jianguo Chen,Ju-Hyun Park,Peixin Lu,Chu Chieh Hsia,Nengjin Wang,Libin Xu,Lingling Lu,Fei Huang,Yuanrong Zhu,Jianhua Lu,Zhengping Ni,Qinan Zhang,Yuying Wu,Guoting Liu,Zhiyuan Wu,Chunfeng Qu,Mitchell H. Gail.Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China[J].Carcinogenesis.2013(8)
  • 7Jun Akiba,Osamu Nakashima,Satoshi Hattori,Ken Tanikawa,Miki Takenaka,Masamich Nakayama,Reiichiro Kondo,Yoriko Nomura,Keiko Koura,Kousuke Ueda,Sakiko Sanada,Yoshiki Naito,Rin Yamaguchi,Hirohisa Yano.Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification[J].The American Journal of Surgical Pathology.2013(4)
  • 8Chern‐Horng Lee,Sen‐Yung Hsieh,Chee‐Jen Chang,Yu‐Jr Lin.Comparison of clinical characteristics of combined hepatocellular‐cholangiocarcinoma and other primary liver cancers[J].J Gastroenterol Hepatol.2012(1)
  • 9Jiayi Huang,Lihong Shen,Yongliang Lu,Hongli Li,Xifeng Zhang,Daixi Hu,Tao Feng,Fangzhou Song.Parallel induction of cell proliferation and inhibition of cell differentiationin hepatic progenitor cells by hepatitis B virus X gene[J].International Journal of Molecular Medicine.2012(4)
  • 10Xin Yin,Bo-Heng Zhang,Shuang-Jian Qiu,Zheng-Gang Ren,Jian Zhou,Xiao-Hong Chen,Ying Zhou,Jia Fan.Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis[J].Annals of Surgical Oncology.2012(9)

共引文献62

同被引文献14

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部